Discrimination of human tumor radioresponsiveness using low-dose rate irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 5, 1998, Pages 1147-1153

  Björk Eriksson, Thomas ^a   West, Catharine ^b   Karlsson, Ewa ^a   Mercke, Claes ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Human tumor cell lines; Human tumors; Low dose rate irradiation; Radiosensitivity

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; UTERINE CERVIX CARCINOMA;

CELL SURVIVAL; HUMANS; MODELS, BIOLOGICAL; RADIATION ONCOLOGY; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TUMOR CELLS, CULTURED;

EID: 0345130011     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00287-9     Document Type: Article

References (42)

1. Fertil B., Malaise E.-P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 7:1981;621-629.
2. Deacon J., Peckham M.J., Steel G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 2:1984;317-323.
3. Malaise E.P., Fertil B., Deschavanne P.J., et al. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res. 111:1987;319-333.
4. Bristow R.G., Hill R.P. Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations . Int J Radiat Oncol Biol Phys. 18:1990;331-345.
5. Tucker S.L., Thames H.D. The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy - a theoretical evaluation. Int J Radiat Oncol Biol Phys. 17:1989;145-157.
6. West C.M.L., Davidson S.E., Roberts S.A., et al. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 68:1993;819-823.
7. West C.M.L., Davidson S.E., Roberts S.A., et al. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 76:(9):1997;1184-1190.
8. Girinsky T., Bernheim A., Lubin R., et al. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation cell characterization and correlations with local control and overall survival . Int J Radiat Oncol Biol Phys. 30:1994;789-794.
9. 2 is it methodology or mythology . Radiother Oncol. 28:1993;187-188.
10. Gerweck L.E., Zaidi S.T. The reproducibility and relationship between single and fractionated dose estimates of the surviving fraction at 2 Gy. Int J Radiat Oncol Biol Phys. 35:(1):1996;81-87.
11. Steel G.G., Deacon J.M., Duchesne G.M., et al. The dose-rate effect in human tumour cells. Radiother Oncol. 9:1987;299-310.
12. Britten R.A., Evans A.J., Allalunis-Turner M.J., et al. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol. 39:1996;145-153.
13. Wilks D.P., Barry J., Hughes M.F., et al. Assessment of light scatter by nucleoids as a rapid predictive assay of radiosensitivity. Radiat Res. 146:1996;628-635.
14. Davidson S.E., West C.M.L., Roberts S.A., et al. Radiosensitvity testing of primary cervical carcinoma evaluation of intra- and inter-tumour heterogeneity . Radiother Oncol. 18:1990;349-356.
15. Björk-Eriksson T., West C.M.L., Karlsson E., et al. The in vitro radiosensitivity of human head and neck cancers. Br J Cancer. 77:1998;2371-2375.
16. Raaphorst G.P., Heller D.P., Bussey A., et al. Thermal radiosensitization by 41°C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines. Int J Hyperthermia. 10:(2):1994;263-270.
17. Shank B. Hyperfractionation versus single dose irradiation in human acute lymfocytic leukemia cells application to TBI for marrow transplantation . Radiother Oncol. 27:1993;30-35.
18. McMillan T.J., Eady J.J., Holmes A., et al. The radiosensitivity of human neuroblastoma a cellular and molecular study . Int J Radiat Biol. 56:(5):1989;651-656.
19. Glück S., Van Dyk J., Messner H.A. Radiosensitivity of human clonogenic myeloma cells and normal bone marrow precursors effect of different dose rates and fractionation . Int J Radiat Oncol Biol Phys. 28:(4):1994;877-882.
20. Cassoni A.M., McMillan T.J., Peacock J.H., et al. Differences in the level of DNA double-strand breaks in human tumour cell lines following low dose-rate irradiation. Eur J Cancer. 28A:(10):1992;1610-1614.
21. Twentyman P.R., Wright K.A., Rhodes T. Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin. Int J Radiat Oncol Biol Phys. 20:1991;217-220.
22. Kelland L.R., Bingle L., Edwards S., et al. High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line. Br J Cancer. 59:1989;160-164.
23. Peacock J.H., Eady J.J., Edwards S.M., et al. The intrinsic a/b ratio for human tumour cells is it a constant? Int J Radiat Biol. 61:(4):1992;479-487.
24. McMillan T.J., Holmes A. The isolation and partial characterization of a radiation-sensitive clone of a human bladder carcinoma cell line. Radiat Res. 128:1991;301-305.
25. Skladowski K., McMillan T.J., Peacock J., et al. Cell-cycle progression during continuous low dose rate irradiation of a human bladder carcinoma cell line. Radiother Oncol. 28:1993;219-227.
26. Chen C., Huang Y., Hall E., et al. Pulsed brachytherapy as a substitute for continuous low dose rate an in vitro study with human carcinoma cells . Int J Radiat Oncol Biol Phys. 37:(1):1997;137-143.
27. Kelland L.R., Steel G.G. Differences in radiation response among human cervix carcinoma cell lines. Radiother Oncol. 13:1988;225-232.
28. Tishler R.B., Geard C.R. Low dose rate irradiation and halogenated pyrimidine effects on human cervical carcinoma cells. Int J Radiat Oncol Biol Phys. 21:1991;975-982.
29. Werts ED, Burholt DR, Paljug WR; et al. Radiation survival of two human cervical carcinoma cell lines after multifraction irradiation. Int J Radiat Oncol Biol Phys 1996; 35(5): 941-950.
30. DeWeese T.L., Walsh J.C., Dillehay L.E., et al. Human papilloma virus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. Int J Radiat Oncol Biol Phys. 37:(1):1997;145-154.
31. Kelland L.R., Burgess L., Steel G.G. Differential radiosensitization by the poly(adp-ribose) transferase inhibitor 3-aminobenzamide in human tumor cells of varying radiosensitivity. Int J Radiat Oncol Biol Phys. 14:1988;1239-1246.
32. Raaphorst G.P., Wang G., Stewart D., et al. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiat Biol. 69:(5):1996;623-631.
33. Kelland L.R., Steel G.G. Dose-rate effects in the radiation response of human tumour xenografts. Radiother Oncol. 7:1986;259-268.
34. Kelland L.R., Bingle L. Radiosensitivity and characterisation of a newly established cell line from an epithelioid sarcoma. Br J Cancer. 58:1988;322-325.
35. Challeton C., Branea F., Schlumberger M., et al. Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumours. Int J Radiat Oncol Biol Phys. 37:(1):1997;163-169.
36. Shahine B.H., Ng C.E., Raaphorst G.P. Modelling of continuous low dose rate and accelerated fractionated high dose rate irradiation treatments in a human glioma cell line. Int J Radiat Biol. 70:(5):1996;555-561.
37. Wilkins D.E., Ng C.E., Raaphorst G.P. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. Int J Radiat Oncol Biol Phys. 36:(1):1996;105-111.
38. Marin L.A., Smith C.E., Langston M.Y., et al. Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys. 21:1991;397-402.
39. McLaughlin P.W., Mancini W.R., Stetson P.L., et al. Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Int J Radiat Oncol Biol Phys. 26:1993;637-642.
40. Yang X., Darling J.L., McMillan T.J., et al. Heterogeneity of radiosensitivity in a human glioma cell line. Int J Radiat Oncol Biol Phys. 22:1991;103-108.
41. Rofstad E.K., Brustad T. Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo (relationship to the initial slope of the cell survival curves in vitro. Radiother Oncol. 9:1987;45-56.
42. Danielsen T., Skøyum R., Rofstad E.K. Hypoxia-induced changes in radiation sensitivity in human melanoma cells importance of oxygen-regulated proteins, adenylate energy charge and cell cycle distribution . Radiother Oncol. 44:1997;177-182.